{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:14:21Z","timestamp":1786997661505,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","transplantation-proceedings.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.transproceed.2017.01.025","type":"journal-article","created":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T09:59:29Z","timestamp":1490176769000},"page":"420-424","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Preliminary Screening Results of Fabry Disease in Kidney Transplantation Patients: A Single-Center Study"],"prefix":"10.1016","volume":"49","author":[{"given":"M.","family":"Y\u0131lmaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.K.","family":"U\u00e7ar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"A\u015f\u00e7\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Canda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.A.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ho\u015fco\u015fkun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"\u00c7oker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"T\u00f6z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2017.01.025_bib1","series-title":"The metabolic and molecular bases of inherited disease","first-page":"3733","article-title":"a-Galactodidase A deficiency: Fabry disease","author":"Desnick","year":"2001"},{"key":"10.1016\/j.transproceed.2017.01.025_bib2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1056\/NEJM199508033330504","article-title":"An atypical variant of Fabry's disease in men with left ventricular hypertrophy","volume":"333","author":"Nakao","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2017.01.025_bib3","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","article-title":"Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy","volume":"138","author":"Desnick","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.transproceed.2017.01.025_bib4","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1523-1755.2003.00160.x","article-title":"Fabry disease: detection of undiagnosed hemodialysis patients and identification of a \u201crenal variant\u201d phenotype","volume":"64","author":"Nakao","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2017.01.025_bib5","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s10545-007-0521-2","article-title":"Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry","volume":"30","author":"Eng","year":"2007","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"Suppl.\u00a0I","key":"10.1016\/j.transproceed.2017.01.025_bib6","first-page":"113","article-title":"Screening for Fabry disease in\u00a0end stage nephropathies","volume":"25","author":"Spada","year":"2002","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.transproceed.2017.01.025_bib7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1432-2277.2008.00791.x","article-title":"Anderson-Fabry disease: a case-finding study among male kidney transplant recipients in Austria","volume":"22","author":"Kleinert","year":"2009","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2017.01.025_bib8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0009-8981(01)00478-8","article-title":"Fabry disease: enzymatic diagnosis in dried blood spots on filter paper","volume":"308","author":"Chamoles","year":"2001","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.transproceed.2017.01.025_bib9","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s10157-005-0369-4","article-title":"Significance of screening for Fabry disease among male dialysis patients","volume":"9","author":"Ichinose","year":"2005","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.transproceed.2017.01.025_bib10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/jmg.2009.072116","article-title":"Screening for Fabry disease in high-risk populations: a systematic review","volume":"47","author":"Linthorst","year":"2010","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.transproceed.2017.01.025_bib11","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1744-9987.2012.01092.x","article-title":"Alpha-galactosidase A activity levels in Turkish male hemodialysis patients","volume":"16","author":"Kalkan U\u00e7ar","year":"2012","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.transproceed.2017.01.025_bib12","doi-asserted-by":"crossref","first-page":"506","DOI":"10.5414\/CNP75506","article-title":"Fabry disease: results of the first UK hemodialysis screening study","volume":"75","author":"Wallin","year":"2011","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.transproceed.2017.01.025_bib13","first-page":"11","article-title":"Frequency of Fabry disease in male and female haemodialysis patients in Spain","volume":"1","author":"Gaspar","year":"2010","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.transproceed.2017.01.025_bib14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s10545-006-0484-8","article-title":"The Dutch Fabry cohort: diversity of clinical manifestations and Gb3 levels","volume":"30","author":"Vedder","year":"2007","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.transproceed.2017.01.025_bib15","doi-asserted-by":"crossref","first-page":"281","DOI":"10.5414\/CNP64281","article-title":"Identification of Fabry's disease by the screening of alpha-galactosidase A activity in male and female hemodialysis patients","volume":"64","author":"Tanaka","year":"2005","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.transproceed.2017.01.025_bib16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1523-1755.2002.00097.x","article-title":"Patients with Fabry disease on dialysis in the United States","volume":"61","author":"Thadhani","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2017.01.025_bib17","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1093\/ndt\/gfn370","article-title":"Two-tier approach for the detection of alpha-galactosidase A deficiency in kidney transplant recipients","volume":"23","author":"DeSchoenmakere","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2017.01.025_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmedgenet-2013-101857","article-title":"A\u00a0systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance","volume":"51","author":"Van der Tol","year":"2014","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.transproceed.2017.01.025_bib19","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1136\/heartjnl-2011-300364","article-title":"Prevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease Survey","volume":"97","author":"Elliott","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.transproceed.2017.01.025_bib20","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/humu.10275","article-title":"Fabry disease: characterization of alpha-galactosidase A double mutations and the D313Y plasma enzyme pseudodeficiency allele","volume":"22","author":"Yasuda","year":"2003","journal-title":"Hum Mutat"},{"key":"10.1016\/j.transproceed.2017.01.025_bib21","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/01.icu.0000143688.45232.15","article-title":"Drug-induced corneal complications","volume":"15","author":"Hollander","year":"2004","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.transproceed.2017.01.025_bib22","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ejpain.2011.01.014","article-title":"The relation between small nerve fibre function, age, disease severity and pain in Fabry disease","volume":"15","author":"Biegstraaten","year":"2011","journal-title":"Eur J Pain"},{"issue":"Suppl. 447","key":"10.1016\/j.transproceed.2017.01.025_bib23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/08035320510028111","article-title":"Is globotriaosylceramide a useful biomarker in Fabry disease?","volume":"94","author":"Young","year":"2005","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.transproceed.2017.01.025_bib24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12863-015-0267-z","article-title":"Increased glycolipid storage produced by the inheritance of a complex intronic haplotype in the \u03b1-galactosidase A (GLA) gene","volume":"16","author":"Gervas-Arruga","year":"2015","journal-title":"BMC Genet"},{"issue":"25","key":"10.1016\/j.transproceed.2017.01.025_bib25","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.jacc.2007.06.062","article-title":"Prevalence of Fabry disease in acohort of 508 unrelated patients with hypertrophic cardiomyopathy","volume":"50","author":"Monserrat","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.transproceed.2017.01.025_bib26","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1096-7192(03)00136-7","article-title":"FD: D313Y is an \u03b1-galactosidase A sequence variant that causes pseudodeficient activity in plasma","volume":"80","author":"Froissart","year":"2003","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.transproceed.2017.01.025_bib27","doi-asserted-by":"crossref","first-page":"e55565","DOI":"10.1371\/journal.pone.0055565","article-title":"Multifocal white matter lesions associated with the D313Y mutation of the alpha-galactosidase A gene","volume":"8","author":"Lenders","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.transproceed.2017.01.025_bib28","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/ndt\/gfp105","article-title":"Nephropathy in Fabry disease: the importance of early diagnosis and testing in high-risk populations","volume":"24","author":"Oqvist","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2017.01.025_bib29","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.clinbiochem.2014.02.014","article-title":"Fabry disease: A new approach for the screening of females in high-risk groups","volume":"47","author":"Pasqualim","year":"2014","journal-title":"Clin Biochem"},{"key":"10.1016\/j.transproceed.2017.01.025_bib30","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ijcard.2014.09.001","article-title":"Uncertain diagnosis of Fabry disease: consensus recommendation on diagnosis in adults with left ventricular hypertrophy and genetic variants of unknown significance","volume":"177","author":"Smid","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.transproceed.2017.01.025_bib31","first-page":"806","article-title":"Simultaneous multicystic kidney and Anderson-Fabry disease: 2 separate entities or same side of the coin","volume":"24","author":"Pisani","year":"2011","journal-title":"J\u00a0Nephrol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134517300350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134517300350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T05:21:15Z","timestamp":1535952075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134517300350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0041134517300350"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2017.01.025","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preliminary Screening Results of Fabry Disease in Kidney Transplantation Patients: A Single-Center Study","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2017.01.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}